Overview

SereNeuro Therapeutics develops non-opioid pain relief therapies in the pharmaceutical and biotech space. Its work centers on drug discovery that leverages research into the functional differences in how humans perceive pain, aiming to create targeted treatments rather than opioids. The company’s products are therapeutic candidates designed to modulate pain pathways, with development and eventual commercialization generating revenue. Unlike many peers, SereNeuro emphasizes understanding pain perception heterogeneity to guide its discovery efforts and bring alternatives to opioid-based pain management to healthcare providers and patients. The company’s goal is to advance safer, effective pain relief options and expand non-opioid choices for treating pain.